Blood test may spot active testicular cancer, study seeks proof
NCT ID NCT06060873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a blood test that measures a substance called miRNA-371 can accurately detect active testicular cancer in people who have already had their primary tumor removed. Researchers will compare the blood test results with surgical findings to see how well the test predicts cancer presence. The study involves 418 participants and aims to improve detection and reduce unnecessary procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TESTICULAR GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Loma Linda University Medical Center
RECRUITINGLoma Linda, California, 92530, United States
-
Los Angeles County-USC Medical Center
RECRUITINGLos Angeles, California, 90033, United States
-
Rutgers Cancer Institute of New Jersey / Jack and Sheryl Morris Cancer Center
RECRUITINGNew Brunswick, New Jersey, 08901, United States
-
USC / Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University of Alabama at Birmingham Cancer Center
RECRUITINGBirmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.